Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity extension company and has been receiving regular intravenous stem cell infusion therapy over the past year.
BlockBeats News, August 21st. According to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human life extension. He recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly flown to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." While the company's name was not disclosed due to ongoing rebranding, he emphasized: "This is a future trend - an increasing number of countries are relaxing regulations on stem cell usage."
You may also like
The large models in the United States are moving towards closure in the name of security
From the white-haired stock god to the billionaire fund mogul, the smart people shorting Nvidia are all getting rich using the same framework
Morning Report | CoinEx becomes a key hub for Iran to evade sanctions, involving over $3.8 billion in funds; Kalshi seeks a new round of financing, with a valuation potentially rising to $40 billion
Global Launch: As predictions become the most scarce asset in the AI era, Manadia is defining the next generation of the value internet
Why do cryptocurrency projects always like to change their names?
Who is footing the bill for the $64 billion accounting frenzy?
I never expected that the first application of AI x Crypto would be in security auditing
What is your view on Binance's competitive advantages?
ETH has entered a non-consensus phase, and the turning point is approaching!
The shift in the cloud of the air: from despising stablecoins a year ago to the high-profile entry of capital today
The survival dilemma of small and medium exchanges behind the withdrawal anomalies exposed by AscendEX
Why Is Bitcoin Falling Below $60K? 5 Key Market Drivers Explained
Bitcoin has dropped sharply amid ETF outflows, Strategy stock weakness, AI stock rallies, and changing Fed expectations. Explore the key forces driving BTC’s latest correction and what traders should watch next.
